These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7617470)

  • 41. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain.
    Guo X; Zheng H; Guo Y; Wang Y; Anderson GJ; Ci Y; Yu P; Geng L; Chang YZ
    J Nanobiotechnology; 2017 Jun; 15(1):42. PubMed ID: 28578696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short communication: the use of sodium ironedetate (Sytron) as an MRI rectal contrast agent.
    Buxton PJ
    Br J Radiol; 1996 Mar; 69(819):266-8. PubMed ID: 8800872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferrite particles as an MR contrast agent.
    Saini S; Ferrucci JT
    Radiology; 1988 Dec; 169(3):656. PubMed ID: 3186987
    [No Abstract]   [Full Text] [Related]  

  • 45. Ferric ammonium citrate-cellulose paste for opacification of the esophageal lumen on MRI.
    Ogawa Y; Noda Y; Morio K; Nishioka A; Inomata T; Yoshida S; Toki T; Ogoshi S
    J Comput Assist Tomogr; 1996; 20(3):455-9. PubMed ID: 8626911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferric Ammonium Citrate Upregulates PD-L1 Expression through Generation of Reactive Oxygen Species.
    Choi EJ; Jeon CH; Lee IK
    J Immunol Res; 2022; 2022():6284124. PubMed ID: 35083343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. L-glutamine as a T
    Joo CG; Yang SH; Choi Y; Son HY; Kim DH; Huh YM
    Magn Reson Med; 2020 Oct; 84(4):2055-2062. PubMed ID: 32406063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
    Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.